AXSOME THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.54 USD | -0.29% |
|
+2.25% | -5.67% |
| 06-05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
| 06-05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.55B | - | |||||
| 93.19B | ||||||
| 39.62B | ||||||
| 33.78B | ||||||
| 26.82B | ||||||
| 15.35B |
